Drugs / Dendritic Cells (DC) prostate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01278914 | Feb 2002 → Aug 2004 | prostate cancer | Oslo University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dendritic Cells (DC) prostate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01278914 ↗ |
| Modality | Cell therapy | “mRNA- Transfected Dendritic Cells” NCT01278914 ↗ |